Last week Cybin (CYBN.NE) announced it was targetting alcoholism with its novel psychedelic compound CYB003. Another EG staffer wrote a piece last Monday outlining the details of the plan,…
CYBN.NE
Cybin (CYBN.NE) announced that they will be using Alcohol Use Disorder (AUD) as the initial target indication for their proprietary psychedelic molecule, CYB003. To read full article: https://equity.guru/2021/04/26/cybin-cybn-ne-to-target-alcoholism-in-their-cyb003-clinical-studies/…
Cybin (CYBN.NE) announced that they will be using Alcohol Use Disorder (AUD) as the initial target indication for their proprietary psychedelic molecule, CYB003. “AUD is a chronic relapsing brain…
Cybin (CYBN.NE) announced that they have successfully demonstrated Proof of Concept for their deuterated tryptamine programs, CYB003 and CYB004. The Proof of Concept revolves around the duration of psilocybin….
Cybin (CYBN.NE) announced they are forming a Clinical Advisory Board, which will be chaired by Alex Belser, Cybin’s Chief Clinical Officer. The board will consist of Belser (PhD), Maurizio…
It’s 2031, COVID is long gone. Jose Conseco is president of the USA. Jeff Bezos redesigns the human digestive system to not need food or water Peter Thiel spends…
EQUITY. GURU MARKET NEWS – LIVE FEED Tuesday, April 13th, 2021 [12:17] CLS Holdings (CLSH.C) announces cannabis dispensary revenues up 100% YOY Retail subsidiary, Oasis Cannabis, achieved a 100.3%…
Cybin (CYBN.NE) announced its plans to advance the pre-clinical work for two of its molecules: its orally dissolving tablet (ODT) formulation CYB003 and its inhaled formulation CYB004. These…
“The truth is that everyone is bored, and devotes himself to cultivating habits.” – Albert Camus, The Plague E-commerce For decades companies have invested billions trying to understand consumer behavior,…
Cybin (CYBN.NE) announced changes to the senior management team effective immediately, with some positions being filled by new members of the team and other current management moving to new…